AXIS Medical Education - AXISMedEd

AXIS Medical Education

Welcome to
AXIS Medical Education

Where Education and Clinical Practice Intersect^®

Popular

Redefining Treatment at First Relapse in RRMM: Exploring BCMA-Targeted Therapies
Redefining Treatment at First Relapse in RRMM: Exploring BCMA-Targeted Therapies
CME/CE
Redefining Treatment at First Relapse in RRMM: Exploring BCMA-Targeted Therapies
0.50 credits
- Sagar Lonial, MD, FACP
- Meghan Berkenstock, MD
- Saad Z. Usmani, MD, MBA, FACP
0.50 credits
Community Practice Perspectives: Exploring Treatment Intensification with CDK4/6 Inhibitors in Adjuvant HR+, HER2−, High-Risk Early Breast Cancer
Community Practice Perspectives: Exploring Treatment Intensification with CDK4/6 Inhibitors in Adjuvant HR+, HER2−, High-Risk Early Breast Cancer
CME/CE
Community Practice Perspectives: Exploring Treatment Intensification with CDK4/6 Inhibitors in Adjuvant HR+, HER2−, High-Risk Early Breast Cancer
0.50 credits
- Adam Brufsky, MD, PhD
0.50 credits
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
CME/CE
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
0.50 credits
- Helena Yu, MD
0.50 credits
Chairperson Perspective: Practice-Changing Strategies in Community Care Settings for Patients with CLL/SLL and MCL
Chairperson Perspective: Practice-Changing Strategies in Community Care Settings for Patients with CLL/SLL and MCL
CME/CE
Chairperson Perspective: Practice-Changing Strategies in Community Care Settings for Patients with CLL/SLL and MCL
0.50 credits
- Matthew S. Davids, MD, MMSc
0.50 credits
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer
CME/CE
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer
0.50 credits
- Joshua E. Reuss, MD
0.50 credits
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ovarian Cancer: Cytogenetic Testing and PARP Inhibition for Maintenance Treatment
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ovarian Cancer: Cytogenetic Testing and PARP Inhibition for Maintenance Treatment
CME/CE
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ovarian Cancer: Cytogenetic Testing and PARP Inhibition for Maintenance Treatment
1.00 credit
- Kathleen Moore, MD, MS, FASCO
1.00 credit
Expert Answers to Common Questions for Tailoring ADC Therapies Across the HER2 Spectrum in Metastatic Breast Cancer
Expert Answers to Common Questions for Tailoring ADC Therapies Across the HER2 Spectrum in Metastatic Breast Cancer
CME/CE
Expert Answers to Common Questions for Tailoring ADC Therapies Across the HER2 Spectrum in Metastatic Breast Cancer
0.25 credits
- Sara M. Tolaney, MD, MPH
0.25 credits
Expert Answers to Common Questions for Improving the Road to Remission with CAR T-Cell Therapies in Large B-Cell Lymphoma: Considerations for Community Practice
Expert Answers to Common Questions for Improving the Road to Remission with CAR T-Cell Therapies in Large B-Cell Lymphoma: Considerations for Community Practice
CME/CE
Expert Answers to Common Questions for Improving the Road to Remission with CAR T-Cell Therapies in Large B-Cell Lymphoma: Considerations for Community Practice
0.25 credits
- Caron A. Jacobson, MD
0.25 credits

CME

Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer
CME/CE
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer
0.25 credits
- Sara M. Tolaney, MD, MPH
0.25 credits
Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned
Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned
Oncology and Hematology
Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned
- Joseph Kim, MD, MPH
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
CME/CE
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
0.50 credits
- Matthew Lunning, DO, FACP
0.50 credits

Medical News

Medical News
Wearable Electrical Nerve Stimulation Device Eases Long COVID Pain and Fatigue, Say Researchers
medicalxpress.com
12/05/2024
Read more
Medical News
Mobile Apps Helpful in Rheumatoid Arthritis Self-Care and Symptom Management
emjreviews.com
12/05/2024
Read more
Medical News
Distinct Melanoma Tumor Characteristics Identified in Pediatric, Adolescent and Young Adult Patients
medicalxpress.com
12/04/2024
Read more
Medical News
Robotic-Assisted Cervical Suspension Using Autologous Tendon Shows Promise for Uterine Prolapse
medicalxpress.com
12/03/2024
Read more
Medical News
Immune Checkpoint Inhibitors Linked to Increased Psoriasis Risk
emjreviews.com
12/03/2024
Read more
Medical News
Stereotactic Radiosurgery Superior to Observation for Koos Grade I Vestibular Schwannomas
medicalxpress.com
12/02/2024
Read more
Medical News
Symptom Screening Reduces Symptom Burden in Pediatric Cancer Patients, Study Finds
eurekalert.org
12/02/2024
Read more
Medical News
ASTRO Updates Guideline on Radiation Therapy for Locally Advanced Rectal Cancer
newswise.com
12/02/2024
Read more